After a review of this article it appears that some new software for business intelligence is entering the picture, either that or some major update to bring in new features. By May 2009, the new guidelines are to be in place.  If you are looking for grants this might be worth reading to be updated.  There will be restructured applications and the bar has risen over the last couple years and it appears now the system will be further automated to deal and work with the growing number of applications and R and D projects approved, which makes sense to keep on top and timely review potential candidates for funding.  Just recently announced the second amended grant submission process is being phased out as well.  BD 

NEW YORK (GenomeWeb News) – The National Institutes of Health this week provided an update on several aspects of its new peer-review policy.

In three separate announcements, the agency updated its timeline for implementing a set of changes to its peer review system, described upcoming changes to its scoring system, and announced enhancements to its review criteria for judging applications.

The NIH began developing potential changes for the peer-review systems in 2007, and in September 2008 it announced when the new policies will take effect.

In January 2010, NIH will implement shorter applications for R01 grants for 2011 funding, and restructured applications that will align with review criteria. The new system will use a nine-point rating scale, with one being best and nine poorest, in order to create a scale with sufficient range.

Reviewers will consider the significance of a project, how the investigators are suited for the project, how the project challenges current research or clinical paradigms, the overall strategy, methodology and approach, and how the scientific environment may contribute to the project’s success.

Some of the other criteria reviewers will consider include protections for human subjects; the inclusion of women, minorities, and children; the involvement of live vertebrate animals; and if applications are resubmissions, renewals, or revised applications.

http://www.genomeweb.com/issues/news/151130-1.html?CMP=OTC-RSS

Related Reading:

NIH to Phase Out Second Amended Grant Submissions

NIH Suspends Emory Grant Amid Questions Over Pharma Payments

FDA and NIH Using Twitter for Updates – The Government Twitter Battle has been won

National Institutes Of Health Launches ClinicalTrials Results Database

Forensic Breakthrough Stirs NIH to Close GWAS Data from Public View

Free Cancer Research Tools Available for Clinical Researchers

0 comments :

Post a Comment

 
Top
Google Analytics Alternative